invIOs INNOVATIVE IMMUNO-ONCOLOGY Email Format

Biotechnology ResearchWien, Austria11-50 Employees

invIOs is a private biotechnology company based in Vienna, Austria, focused on discovery and development of novel cancer therapeutics that harness the immune system to fight cancer. The company emphasizes early-stage development, aiming to move assets from discovery and preclinical stages into clinical trials, with a pipeline of individualized and targeted approaches against solid tumors. Launched in 2022 as a spin-out consolidating oncology assets from APEIRON Biologics, invIOs employs about 35 people with in-house capabilities spanning R&D, clinical development, CMC, IP, scouting and related functions. The company collaborates with academic and clinical institutions, including the Dana-Farber Cancer Institute, on programs such as glioblastoma research and preclinical assessment of candidates like INV501. invIOs operates in the biotechnology research sector with a focus on immuno-oncology and solid-tumor indications.

Get verified invIOs INNOVATIVE IMMUNO-ONCOLOGY emails free

Company overview Employee directory